دورية أكاديمية
An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level.
العنوان: | An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level. |
---|---|
المؤلفون: | Liu X; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Gillis N; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America., Jiang C; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida, United States of America., McCofie A; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Shaw TI; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Tan AC; Department of Oncological Sciences, Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, United States of America., Zhao B; Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America., Wan L; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida, United States of America., Duckett DR; Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida, United States of America., Teng M; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America. |
المصدر: | PLoS computational biology [PLoS Comput Biol] 2024 Feb 09; Vol. 20 (2), pp. e1011873. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: San Francisco, CA : Public Library of Science, [2005]- |
مواضيع طبية MeSH: | Super Enhancers* , Neoplasms*/genetics, Humans ; Epigenomics ; Enhancer Elements, Genetic/genetics ; Gene Expression Regulation |
مستخلص: | Super enhancers (SE), large genomic elements that activate transcription and drive cell identity, have been found with cancer-specific gene regulation in human cancers. Recent studies reported the importance of understanding the cooperation and function of SE internal components, i.e., the constituent enhancers (CE). However, there are no pan-cancer studies to identify cancer-specific SE signatures at the constituent level. Here, by revisiting pan-cancer SE activities with H3K27Ac ChIP-seq datasets, we report fingerprint SE signatures for 28 cancer types in the NCI-60 cell panel. We implement a mixture model to discriminate active CEs from inactive CEs by taking into consideration ChIP-seq variabilities between cancer samples and across CEs. We demonstrate that the model-based estimation of CE states provides improved functional interpretation of SE-associated regulation. We identify cancer-specific CEs by balancing their active prevalence with their capability of encoding cancer type identities. We further demonstrate that cancer-specific CEs have the strongest per-base enhancer activities in independent enhancer sequencing assays, suggesting their importance in understanding critical SE signatures. We summarize fingerprint SEs based on the cancer-specific statuses of their component CEs and build an easy-to-use R package to facilitate the query, exploration, and visualization of fingerprint SEs across cancers. Competing Interests: The authors have declared that no competing interests exist. (Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.) |
References: | Nature. 2019 May;569(7757):503-508. (PMID: 31068700) Nucleic Acids Res. 2019 Dec 16;47(22):11481-11496. (PMID: 31724731) Mol Cell. 2010 May 28;38(4):576-89. (PMID: 20513432) Nat Biotechnol. 2021 Jul;39(7):819-824. (PMID: 33846646) Trends Cancer. 2017 Apr;3(4):269-281. (PMID: 28718439) Nucleic Acids Res. 2022 Apr 8;50(6):3115-3127. (PMID: 35234924) Nature. 2007 Mar 8;446(7132):153-8. (PMID: 17344846) Genome Biol. 2018 Apr 24;19(1):54. (PMID: 29690904) Cell Rep. 2018 Apr 10;23(2):349-360. (PMID: 29641996) Bioinformatics. 2014 Apr 1;30(7):923-30. (PMID: 24227677) Mol Cell. 2014 Oct 23;56(2):187-189. (PMID: 25373538) Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5. (PMID: 27079975) Cell. 2018 Apr 5;173(2):371-385.e18. (PMID: 29625053) Nat Commun. 2021 Mar 3;12(1):1419. (PMID: 33658503) Nat Methods. 2020 Aug;17(8):807-814. (PMID: 32737473) Cell. 2018 Apr 5;173(2):386-399.e12. (PMID: 29625054) Nat Genet. 2014 Dec;46(12):1311-20. (PMID: 25383968) Genome Biol. 2014;15(12):550. (PMID: 25516281) Genome Biol. 2021 Apr 15;22(1):108. (PMID: 33858480) Elife. 2013 Jun 18;2:e00808. (PMID: 23795297) Nat Commun. 2018 Mar 5;9(1):943. (PMID: 29507293) Nat Genet. 2020 Aug;52(8):778-789. (PMID: 32661416) Science. 2008 Dec 19;322(5909):1845-8. (PMID: 19056941) Genome Biol. 2020 Sep 15;21(1):247. (PMID: 32933554) Nature. 2022 Jun;606(7916):984-991. (PMID: 35705804) Cell. 2013 Nov 7;155(4):934-47. (PMID: 24119843) Nature. 2020 Feb;578(7793):82-93. (PMID: 32025007) Mol Syst Biol. 2021 Jan;17(1):e9873. (PMID: 33502116) Genome Biol. 2021 Sep 15;22(1):269. (PMID: 34526084) Nat Biotechnol. 2021 Jul;39(7):825-835. (PMID: 33846645) Cell. 2013 Apr 11;153(2):320-34. (PMID: 23582323) Genome Biol. 2010;11(2):R22. (PMID: 20181287) Biometrics. 1999 Jun;55(2):463-9. (PMID: 11318201) Nature. 2020 Feb;578(7793):94-101. (PMID: 32025018) Mol Cell. 2015 Apr 16;58(2):362-70. (PMID: 25801169) Nat Genet. 2016 Feb;48(2):176-82. (PMID: 26656844) NAR Genom Bioinform. 2021 Oct 14;3(4):lqab098. (PMID: 34661103) Cell. 2013 Apr 11;153(2):307-19. (PMID: 23582322) Bioinform Biol Insights. 2021 Feb 9;15:1177932220974623. (PMID: 33623376) Nat Methods. 2012 Mar 04;9(4):357-9. (PMID: 22388286) Genome Biol. 2008;9(9):R137. (PMID: 18798982) Nat Rev Genet. 2012 Sep;13(9):613-26. (PMID: 22868264) Cell. 2017 Feb 9;168(4):629-643. (PMID: 28187285) Science. 2013 Feb 22;339(6122):950-3. (PMID: 23430654) Bioinformatics. 2015 Nov 15;31(22):3718-20. (PMID: 26209431) Sci Rep. 2019 Jun 27;9(1):9354. (PMID: 31249361) Nucleic Acids Res. 2020 Jan 8;48(D1):D882-D889. (PMID: 31713622) Cell. 2018 Apr 5;173(2):291-304.e6. (PMID: 29625048) Nat Commun. 2019 Apr 29;10(1):1930. (PMID: 31036827) Nature. 2018 Jan 25;553(7689):515-520. (PMID: 29342133) Genome Res. 2012 Feb;22(2):407-19. (PMID: 21613409) Nat Genet. 2018 Aug;50(8):1151-1160. (PMID: 29988121) Cell. 2018 Apr 5;173(2):321-337.e10. (PMID: 29625050) Science. 2013 Mar 1;339(6123):1074-7. (PMID: 23328393) Nat Commun. 2020 Dec 9;11(1):6318. (PMID: 33298918) |
معلومات مُعتمدة: | R01 CA255398 United States CA NCI NIH HHS; R01 AI123420 United States AI NIAID NIH HHS; R01 CA262530 United States CA NCI NIH HHS; P30 CA076292 United States CA NCI NIH HHS; R03 DE030580 United States DE NIDCR NIH HHS |
تواريخ الأحداث: | Date Created: 20240209 Date Completed: 20240223 Latest Revision: 20240224 |
رمز التحديث: | 20240224 |
مُعرف محوري في PubMed: | PMC10883583 |
DOI: | 10.1371/journal.pcbi.1011873 |
PMID: | 38335222 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1553-7358 |
---|---|
DOI: | 10.1371/journal.pcbi.1011873 |